Introducing

A wound dressing that supports the continuous debridement1 of slough with the benefit of silver

Any support for a continuous debridement
solution must be:

  1. Effective
    Continuously removes slough and wound debris and mitigates reformation of microbial colonies post sharp debridement.
  2. Accessible
    All caregivers can harness the benefits of sharp debridement, throughout the continuum of care.
  3. Easy & Comfortable
    Easy to use by healthcare providers and well tolerated by patients.

Introducing

Urgo Clean Ag Logo
UrgoClean Ag Interface with icons for mobile
urgoclean ag charged fibers
Charged fibers* support the continuous debridement of slough1
Fibrin, microorganisms, and wound residue attach to the negatively charged fibers to continuously clean the wound bed2,3,4
Urgo's TLC ag matrix
The TLC-Ag matrix
Fast, broad-spectrum, antimicrobial-barrier efficacy5
The TLC (technology lipidocolloid) matrix creates a bio-friendly gel that supports a wound environment conducive to wound healing​​6
The gel allows for atraumatic, one-piece removal, minimizing trauma and discomfort while maintaining its integrity
up to seven days4,6,7
    * Electrostatic forces between negatively charged fibers and positively charged materials such as slough

    Proven Efficacy

    The Largest Observational Study ever conducted for a silver dressing8
    a green checkmark
    2270 patients including 77 under the age of 18 years old
    a green checkmark
    After only 2 weeks, 90.6% of the wounds treated demonstrated improvement of the healing process
    a green checkmark
    UrgoClean Ag effectively
    reduced exudate level by 70%
    a green checkmark
    Over three weeks, there was a 79% increase in healthy granulation tissue and showing a significant reduction in slough & necrotic tissue
    a green checkmark
    No intolerance to the dressing was documented
    SAWC poster ribbon award
    In a RCT, UrgoClean’s charged-fiber technology showed +50% greater slough reduction compared to Hydrofiber® technology9
    % of desloughed wounds at conclusion of study
    urgoclean rct study data
    an icon for JWC best research award

    See the effects of UrgoClean Ag10

    Diabetic & Ischemic Arterial Wound
    Under the previous care plan, the patient received weekly sharp debridement, alginate, collagen, & off-loading device. The UrgoClean Ag treatment plan included Vashe soaks prior to use of UrgoClean Ag, and Drawtex was used as a secondary dressing and changed daily.
    Arterial Wound during UrgoClean Ag treatment-1
    Arterial Wound during UrgoClean Ag treatment-2
    Arterial Wound during UrgoClean Ag treatment-3
    Arterial Wound during UrgoClean Ag treatment -4
    Pressure Injury
    Under the previous care plan, the patient received weekly sharp debridement, alginate, collagen, & off-loading device. The UrgoClean Ag treatment plan included Vashe soaks prior to use of UrgoClean Ag, and Drawtex was used as a secondary dressing and changed daily.
    Pressure Injury during UrgoClean Ag treatment-1
    Pressure Injury during UrgoClean Ag treatment-2
    Pressure Injury during UrgoClean Ag treatment-3
    Dressing Removal
    UrgoClean Ag dressing removal 2
    UrgoClean Ag dressing removal 1

    How to use

    Urgo Clean Ag Logo
    Step 1: Cleanse the wound and surrounding tissue per your facility’s cleansing protocol (i.e., Vashe® Wound Solution). Pat dry.
    ‍
    Step 2: Open package and remove dressing. Fenestrate dressing with scissors as needed to allow for additional drainage. Remove protective plastic covering before application. DO NOT moisten UrgoClean Ag.‍
    example 2 of how to cut UrgoClean Ag
    example 3 of how to cut UrgoClean Ag
    Step 3: Apply UrgoClean Ag dressing by placing the sticky, brown, diamond side directly onto the wound bed, ensuring intimate contact with the wound. The UrgoClean Ag can be cut to the size of the wound or overlap onto the surrounding tissue. 
    Applying UrgoClean Ag to a wound
    ‍Step 4: Cover UrgoClean Ag with a secondary dressing suitable to the level of exudate, such as Drawtex Hydroconductive Wound Dressing, ABD pads, gauze, etc.
    Covering a wound before application of UrgoClean Ag
    ‍Step 5: Change UrgoClean Ag every 1–3 days depending on drainage volume. It may remain in place for up to 7 days. Wash the wound between dressing changes.
    ‍

    Product information

    A box of UrgoClean Ag U.S.
    Product Code
    Description
    Units
    HCPC Code
    603070
    UrgoClean Ag – 2.5 in x 2.5 in
    10 each/box
    A6196
    603071
    UrgoClean Ag – 4 in x 5 in
    10 each/box
    A6197
    603073
    UrgoClean Ag – 6 in x 8 in
    5 each/box
    A6197
    UrgoClean Ag 2.5 in x 2.5 in
    Product Code: 603070
    Units: 10 each/box
    HCPC Code: A6196

    UrgoClean Ag 4 in x 5 in
    Product Code: 603071
    Units: 10 each/box
    HCPC Code: A6197

    UrgoClean Ag 6 in x 8 in
    Product Code: 603073
    Units: 5 each/box
    HCPC Code: A6197
    ‍

    Clinical support

    For more information about UrgoClean Ag, to order, or to speak with a customer success representative, simply click below.
    ‍
    Connect with us
    References
    1. Reinboldt-Jockenhofer, F. etal. (2025).  Debridement – how efficientcan a wound dressing be? The answer from a large perspective observationalstudy. Journal of Wound Care; 34 (4). 2. LazarethI, et al. The role of a silver releasing lipido-colloidcontact layer invenous leg ulcers presentinginflammatory signs suggesting heavy bacterial colonization: Results of arandomized controlled study. Wounds. 2008;20(6):158–66. 3. Dalac, S. (2016) Clinical Evaluation of a dressing with polyabsorbent fibers and a silver matrix for managing chronic wounds at risk ofinfection: a non comparative trial. Journal of Wound Care; 25. 4. DesrocheN.et al., Characterization of the antimicrobial spectrum and anti-biofilmactivity of a new silver-containing dressing with poly-absorbent fibresand antimicrobial silver matrix. Poster EWMA May 2016. 5. Percival SL, et al., Slough and biofilm: removal of barriers towound healing by desloughing. J Wound Care. 2015 Nov;24(11):498, 500-3, 506-10. 6. White R, Cowan T, Glover D.Supporting evidence-based practice: a clinical review of TLC healing matrix(2nd edition). London: MA Healthcare; 2015; 13 (10). 7. International Wound InfectionInstitute (IWII) Wound Infection in Clinical Practice. Wounds International. 8. DissemondJ, Dietlein M, NeβelerL, Funke L, ScheuermannO,Becker E, Thomassin L, MöllerU, Bohbot S, MúnterKC. Use of a TLC-Ag dressing on 2270 patients with wounds at risk or with signsof local infection: an observational study. J Wound Care. 2020,Mar2;29(3):162-173. 9. Meaume,S., Dissemond,J., Addala, A. Evaluation of two fibrous wounddressingsfor the management of leg ulcers: results of a European randomisedcontrolled trial (EARTH RCT). J Wound Care 2014; 23: 3, 105-116. 10. UrgoClean Ag Clinical Case Lookbook on File.
    Page updated on 14 July 2025
    Copyright © 2024 Urgo Medical North America. All Rights Reserved.
    ‍
    Privacy StatementPolicies & Guidelines